Optimization of conventional therapy in patients with IBD

Randomised clinical trial: early assessment after 2 weeks of high-dose mesalazine for moderately active ulcerative colitis - new light on a familiar question

(2011) T. R. Orchard et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Once daily Asacol

(2011) A. B. Hawthorne et al.   GUT

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

(2010) W. Kruis et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis

(2010) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Analysis of Administrative Data Finds Endoscopist Quality Measures Associated With Postcolonoscopy Colorectal Cancer

(2010) Nancy N. Baxter et al.   GASTROENTEROLOGY

Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

(2010) Christopher D. Williams et al.   GASTROENTEROLOGY

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

(2010) W. Reinisch et al.   GUT

Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates

(2010) A. V. Ramadas et al.   GUT

Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts

(2010) B. Jharap et al.   INFLAMMATORY BOWEL DISEASES

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

(2010) Melissa L. Haines et al.   INFLAMMATORY BOWEL DISEASES

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

(2010) A. Dignass et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

(2009) M. WAHED et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Loss of Response and Requirement of Infliximab Dose Intensification in Crohn's Disease: A Review

(2009) Javier P Gisbert et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease

(2009) Yvette Leung et al.   Journal of Crohns & Colitis

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis

Biologics for inflammatory bowel diseases in the Asia-Pacific: Can we afford to use them, can we afford not to?

(2009) Richard B Gearry et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

(2008) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease

(2008) A. ANSARI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients

(2008) J. P. GISBERT et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease

(2008) U. HINDORF et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study

(2008) Fabrizio Bossa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Thiopurine Dose in Intermediate and Normal Metabolizers of Thiopurine Methyltransferase May Differ Three-Fold

(2008) Sharon J. Gardiner et al.   Clinical Gastroenterology and Hepatology

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

(2008) Geert R. D'Haens et al.   GASTROENTEROLOGY

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

(2008) W Kruis et al.   GUT

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

(2008) Jaya Punati et al.   INFLAMMATORY BOWEL DISEASES

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis

(2008) Michael A. Kamm et al.   INFLAMMATORY BOWEL DISEASES

Impact of ulcerative colitis from patientsʼ and physiciansʼ perspectives

(2008) David T. Rubin et al.   INFLAMMATORY BOWEL DISEASES

Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-Dependent Crohnʼs Disease

(2008) Gerassimos J. Mantzaris et al.   INFLAMMATORY BOWEL DISEASES

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohnʼs disease: A randomized, double-blind, placebo-controlled pilot study

(2008) Kelvin T. Thia et al.   INFLAMMATORY BOWEL DISEASES